Status:
UNKNOWN
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Pfizer
Conditions:
Overactive Bladder
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
OAB is a widespread medical problem affecting 6- 30% of the population (both sexes and all age groups) in Europe1 and 16%2-18%3 of the US and Canadian population. Nevertheless only a small proportion ...
Detailed Description
This study will be a non-randomised, non-placebo controlled prospective clinical trial. We intend to recruit approximately 100 patients that will receive and fill out the questionnaire before and aft...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- OAB score of ≥ 8
- Age 20-80 years old
- Patients must comply and agree to the requirement of taking only Detrusitol 4mg and no other new medication affecting the lower urinary tract system
- Exclusion criteria:
- Patients that are on any other treatment (whether medical or conservative) for OAB.
- Patients with documented UTI.
- Patients who have demonstrated hypersensitivity to the drug or its ingredients.
- Where Detrusitol is contraindicated (i.e. patients with severe outlet obstruction, gastric retention, or uncontrolled narrow-angle glaucoma).
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00313924
Start Date
February 1 2006
End Date
March 1 2006
Last Update
February 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Healthcare Center
Haifa, Israel, 31096